Advancements in Blood Cancer Treatment and Screening Technologies
05/09/2026
Nueva Terapia para la Trombocitemia Esencial La FDA ha aprobado la inyección de ropeginterferón alfa-2b (Besremi) para tratar a adultos
Policies addressing cognitive decline in aging physicians were uncommon in the U.S. and similar countries, a comparative policy analysis showed.…
Read more →
Nueva Terapia para la Trombocitemia Esencial La FDA ha aprobado la inyección de ropeginterferón alfa-2b (Besremi) para tratar a adultos
Injuries from Medical Devices The FDA has issued a warning regarding Boston Scientific’s recalled spinal cord stimulator for chronic limb
Introducción The FDA has recently approved zilganersen (Zanvastro) for the treatment of Alexander disease in both pediatric and adult patients.
After ruling out a myocardial infarction (MI) in patients with suspected acute coronary syndrome (ACS), routine use of CT coronary
UnitedHealthcare (UHC) ha anunciado recientemente la eliminación de 1,700 procedimientos de su lista de autorizaciones previas, un cambio que ha